Press Releases

IR Mobile SiteEmail pagePDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing


Year:
Notify me when new press releases are posted to this site.
Press Releases
4/15/2014Cubist to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014
4/01/2014Cubist Appoints Robert J. Perez to Board of Directors
3/31/2014FDA Advisory Committee Unanimously Recommends Approval of Cubist’s SIVEXTRO™ (Tedizolid Phosphate) as Treatment for Serious Skin Infections
2/27/2014Cubist Announces EMA Acceptance of Tedizolid Marketing Authorization Application for Review
2/13/2014Cubist & Cambridge Science Festival Launch “Germ Challenge” Science Contest
2/10/2014Cubist to Present at February Investor Conferences
1/23/2014Cubist Reports Fourth Quarter and Full Year 2013 Financial Results; Provides 2014 Revenue Guidance
1/13/2014Cubist Announces Fourth Quarter/Full-Year 2013 Revenues; Provides Pipeline Update
1/10/2014Cubist Submits Clinical Trial Application to Initiate First-in-Human Study of CB-618—A Beta-Lactamase Inhibitor Discovered to Combat Antibiotic Resistance
12/30/2013Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
12/16/2013Cubist Announces Positive Top-Line Results from Phase 3 Trial of Ceftolozane/Tazobactam in Intra-Abdominal Infections
11/26/2013Cubist to Present at NASDAQ OMX 30th Investor Conference
More Press Releases...
 
 Source: SNL Financial LC 
Optimer Press Releases
8/1/2013 Optimer Reports Second Quarter 2013 Financial Results
5/9/2013 Optimer Reports First Quarter 2013 Financial Results
4/26/2013 DIFICID® (fidaxomicin) Tablets Approved in Australia
2/28/2013 Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
More Optimer Press Releases...



Trius Press Releases
6/12/2013 Trius Therapeutics Announces Publication of Antibiotic Safety Study in Antimicrobial Agents and Chemotherapy
5/13/2013 Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
4/29/2013 Trius Therapeutics Presents Clinical Data on Experimental Antibiotic Tedizolid at ECCMID Meeting
4/23/2013 Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
More Trius Press Releases...

Copyright 2014, © SNL Financial LC  Terms of Use